COMMUNIQUÉS West-GlobeNewswire

Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results

07/02/2018 - 12:10

Reports record fourth quarter revenue of $131.4 million and full year revenue of $501.0 million Reports fourth quarter GAAP earnings (loss) per share of $(0.22) and non-GAAP of $0.42 PLEASANTON, Calif., Feb. 07, 2018 ( [...]

ViaDerma, Inc. Announced the Dismissal of a Lawsuit Against Them in US District Federal Court

07/02/2018 - 11:00

LOS ANGELES, Feb. 07, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), recently announced the complaint filed by Steven J. Keough in a South Dakota Federal Court, has been dismissed without prejudice. The [...]

Sanofi Delivers 2017 Business EPS(1) in line with Guidance

07/02/2018 - 09:45

Paris, February 7, 2018 Sanofi Delivers 2017 Business EPS (1) in line with Guidance Q4 2017 Change Change at CER Change at CER/CS (2) 2017 Change Change at CER Change at CER/CS (2) IFRS net sales reported €8,691m -2.0 [...]

Sanofi : BNPA des activités(1) de 2017 en ligne avec les perspectives annoncées

07/02/2018 - 09:45

Paris, le 7 février 2018 BNPA des activités (1) de 2017 en ligne avec les perspectives annoncées T4 2017 Variation Var. à TCC Var. à TCC/PC (2) 2017 Variation Var. à TCC Var. à TCC/PC (2) Chiffre d'affaires net IFRS [...]

Saniona AB: Saniona Completes Recruitment in Phase I study with new Tesomet tablet

07/02/2018 - 09:31

PRESS RELEASE February 7, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that it has completed the recruitment of participants into the Phase 1 pharmacokinetic study of Tesomet [...]

Group financial statement for 2017

07/02/2018 - 07:59

Solid 2017. Good momentum set to continue Solid year with 4% organic sales growth (Q4: +4%): Household Care +1%, Food & Beverages +9%, Bioenergy +11%, Agriculture & Feed -3%, Technical & Pharma +2%. EBIT [...]

Annual Report 2017 for H. Lundbeck A/S

07/02/2018 - 07:53

Valby, Denmark, 2018-02-07 07:53 CET (GLOBE NEWSWIRE) -- Annual Report 2017 for H. Lundbeck A/S.

Lundbeck delivers its best financial results following 10% revenue growth and 117% growth in net profit

07/02/2018 - 07:48

Valby, Denmark, 2018-02-07 07:48 CET (GLOBE NEWSWIRE) -- HIGHLIGHTS Revenue reached DKK 17,234 million in 2017 representing an increase of 10% (12% in local currencies) compared to 2016 Revenue of Abilify Maintena ® [...]

Zealand reports royalty revenue for the fourth quarter of 2017

07/02/2018 - 07:34

Company announcement - No. 7/2018 Zealand reports royalty revenue for the fourth quarter of 2017 Zealand reports royalty revenue of DKK 11.3 million/USD 1.8 million for Q4 2017 The revenue is based on total net sales of [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

07/02/2018 - 07:11

REGULATED INFORMATION GHENT, Belgium, 7 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Double-digit growth in revenue and earnings – delivered on guidance

07/02/2018 - 07:08

In 2017, revenue increased by 11% to DKK 9,585 million. Organic growth was 8% EBITA reached DKK 1,744 million, equivalent to a 10% increase, based on strong execution in both GN Hearing and GN Audio Strong cash [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

07/02/2018 - 07:05

REGULATED INFORMATION GHENT, Belgium, 7 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

ABLYNX ANNOUNCES BOARD CHANGES

07/02/2018 - 07:01

GHENT, Belgium, 7 February 2018 - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced that Dr Bo Jesper Hansen, acting as permanent representative of Orfacare Consulting GmbH, has decided to resign from the [...]

Targovax announces completion of safety lead-in and preliminary immune activation data in ONCOS-102 trial in mesothelioma

07/02/2018 - 07:01

Oslo, Norway, 7 February 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces completion of the safety lead-in cohort and [...]

Fagron turnover increased by 3.6% to € 436.9 million and net profit increased to € 47.0 million

07/02/2018 - 07:01

Regulated information | Consolidated results for the 2017 financial year Nazareth (Belgium) / Rotterdam (The Netherlands), 7 February 2018 Fagron turnover increased by 3.6% to € 436.9 million and net profit increased to [...]

Addex Appoints Jean-Philippe Rocher as Co-Head of Discovery and Member of the Executive Management

07/02/2018 - 07:01

Geneva, Switzerland, 7 February 2018 - Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today the appointment of Jean-Philippe Rocher, [...]

Cannabis Wheaton Income Corp. Reminds Warrant Holders of February 15, 2018 Expiry Date

07/02/2018 - 06:01

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V: [...]

Arcturus Therapeutics Issues Statement

07/02/2018 - 05:09

SAN DIEGO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today issued the following statement in response to the 13D filing issued by Joseph E. Payne: We [...]

MacroGenics to Participate in Two Upcoming Investor Conferences

06/02/2018 - 23:30

ROCKVILLE, MD, Feb. 06, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]